Header cover image

Danish (OMX) Healthcare Sector Analysis

UpdatedApr 13, 2024
DataAggregated Company Financials
Companies20
  • 7D1.1%
  • 3M18.9%
  • 1Y43.2%
  • YTD23.8%

Over the last 7 days, the Healthcare industry has remained flat, although notably Zealand Pharma declined by 7.4%. As for the the longer term, the industry is up 45% over the past 12 months. Earnings are forecast to grow by 15% annually.

Sector Valuation and Performance

Has the Danish Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sat, 13 Apr 2024kr.4.5tkr.341.3bkr.99.7b33.5x45.1x13.2x
Mon, 11 Mar 2024kr.4.7tkr.341.2bkr.99.6b39.6x46.7x13.6x
Wed, 07 Feb 2024kr.4.2tkr.338.6bkr.98.5b34.8x42.3x12.3x
Fri, 05 Jan 2024kr.3.8tkr.320.5bkr.90.0b33.1x41.9x11.8x
Sun, 03 Dec 2023kr.3.6tkr.320.5bkr.90.0b32.8x40.3x11.3x
Tue, 31 Oct 2023kr.3.5tkr.305.6bkr.82.3b26.5x42.5x11.4x
Thu, 28 Sep 2023kr.3.4tkr.305.5bkr.82.2b32.9x41.5x11.2x
Sat, 26 Aug 2023kr.3.4tkr.305.2bkr.82.1b35.4x41.2x11.1x
Mon, 24 Jul 2023kr.3.0tkr.287.0bkr.75.4b40.6x40.1x10.6x
Wed, 21 Jun 2023kr.3.0tkr.287.1bkr.75.5b40x39.7x10.4x
Fri, 19 May 2023kr.3.2tkr.285.6bkr.74.6b41.4x42.4x11.1x
Sun, 16 Apr 2023kr.3.2tkr.272.6bkr.68.5b43x46x11.6x
Tue, 14 Mar 2023kr.2.7tkr.292.6bkr.69.2b37.1x39.7x9.4x
Thu, 09 Feb 2023kr.2.8tkr.287.5bkr.68.7b38x40.1x9.6x
Sat, 07 Jan 2023kr.2.8tkr.276.1bkr.66.3b38.3x41.5x10x
Mon, 05 Dec 2022kr.2.6tkr.276.1bkr.66.3b38.4x39.6x9.5x
Wed, 02 Nov 2022kr.2.4tkr.261.3bkr.62.4b37.3x38.2x9.1x
Fri, 30 Sep 2022kr.2.2tkr.261.3bkr.62.4b33.6x35.5x8.5x
Sun, 28 Aug 2022kr.2.4tkr.260.2bkr.62.5b36.7x38.9x9.3x
Tue, 26 Jul 2022kr.2.5tkr.247.8bkr.59.9b37.7x41.4x10x
Thu, 23 Jun 2022kr.2.2tkr.247.6bkr.59.9b34.3x37.5x9.1x
Sat, 21 May 2022kr.2.3tkr.247.8bkr.59.8b35x38.2x9.2x
Mon, 18 Apr 2022kr.2.5tkr.238.0bkr.59.8b38.6x41.5x10.4x
Wed, 16 Mar 2022kr.2.2tkr.238.0bkr.59.8b38.3x36x9x
Fri, 11 Feb 2022kr.2.2tkr.236.9bkr.59.4b38.8x36.4x9.1x
Sun, 09 Jan 2022kr.2.2tkr.229.2bkr.57.8b50.5x37.9x9.6x
Tue, 07 Dec 2021kr.2.3tkr.229.2bkr.57.8b52.4x39.5x9.9x
Thu, 04 Nov 2021kr.2.4tkr.223.4bkr.55.5b56.7x43.5x10.8x
Sat, 02 Oct 2021kr.2.1tkr.223.3bkr.55.6b61.6x37.9x9.4x
Mon, 30 Aug 2021kr.2.2tkr.223.2bkr.55.6b68x40.3x10.1x
Tue, 06 Jul 2021kr.1.9tkr.223.2bkr.55.6b65.5x35x8.7x
Price to Earnings Ratio

31.4x


Total Market Cap: kr.1.8tTotal Earnings: kr.56.6bTotal Revenue: kr.221.0bTotal Market Cap vs Earnings and Revenue0%0%0%
Danish Healthcare Sector Price to Earnings3Y Average 39.6x202220232024
Current Industry PE
  • Investors are optimistic on the Danish Healthcare industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 44.8x which is higher than its 3-year average PE of 39.6x.
  • The 3-year average PS ratio of 10.1x is lower than the industry's current PS ratio of 13.1x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have grown 21% per year over the last three years.
  • Revenues for these companies have grown 16% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Danish Healthcare sector?

DK Market0.40%
Healthcare1.10%
Pharma1.44%
Medical Equipment-1.04%
Biotech-1.33%
Healthtech-1.90%
Healthcare Services-4.59%
Life Sciences-14.00%
Industry PE
  • Investors are most optimistic about the Healthtech industry which is trading above its 3-year average PE ratio of 45.8x.
    • Analysts are expecting annual earnings growth of 57.0% and investors are willing to pay a premium for that growth.
  • Investors are most pessimistic about the Healthcare Services industry, which is trading close to its 3-year average of 17.7x.
Forecasted Growth
  • Analysts are most optimistic on the Healthtech industry, expecting annual earnings growth of 57% over the next 5 years.
  • In contrast, the Medical Equipment industry is expected to see its earnings grow by 14% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
NOVO B Novo Nordiskkr.880.001.4%
+kr.55.6b
53.8%PE46.9x
HLUN B H. Lundbeckkr.33.901.9%
+kr.634.9m
1.3%PE14.7x
GMAB Genmabkr.2.07k0.5%
+kr.500.0m
-26.6%PE30.9x
ALK B ALK-Abellókr.124.600.6%
+kr.177.0m
13.3%PE56.7x
MONSO Monsensokr.0.434.9%
+kr.7.8m
50.3%PS3x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

CHEMM

kr.295.00

ChemoMetec

7D

-21.7%

1Y

-21.0%

HLUN B

kr.33.90

H. Lundbeck

7D

1.9%

1Y

1.3%

GMAB

kr.2,067.00

Genmab

7D

0.5%

1Y

-26.6%

NOVO B

kr.880.00

Novo Nordisk

7D

1.4%

1Y

53.8%

ZEAL

kr.589.50

Zealand Pharma

7D

-7.4%

1Y

167.7%

MONSO

kr.0.43

Monsenso

7D

4.9%

1Y

50.3%